|
Wednesday, November 17, 2021
Print Current Session:
 |
|
|
Wednesday
SESSION 24:
NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) (ALL TALKS ARE 5 MINUTES)
|
|
| SESSION 24 SCHEDULE | |
| PROGRESS IN ATHERECTOMY | |
| 7:53 AM - 7:58 AM | New Developments In Laser Atherectomy: What Makes It Different: When Is It Beneficial With Certainty |
|
Presenter(s):George L. Adams, MD Location: Grand Ballroom East, 3rd Floor |
|
| 7:59 AM - 8:04 AM | Value Of Phoenix Atherectomy And Stellarex DCB For Infrapopliteal Lesions: Why IVUS Guidance Is Beneficial: 1-Yea Results In CLTI Patients |
|
Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:05 AM - 8:10 AM | Optical Coherence Tomography (OCT) Guided Atherectomy (Pantheris) For In Stent Restenosis (ISR): Why It Is More Effective Treatment: From The INSIGHT Trial |
|
Presenter(s):Todd R. Vogel, MD, MPH Location: Grand Ballroom East, 3rd Floor |
|
| 8:11 AM - 8:16 AM | Current Role Of Atherectomy In Treating Lower Extremity CLTI: A Vascular Surgeon’s View |
|
Presenter(s):James F. McKinsey, MD Location: Grand Ballroom East, 3rd Floor |
|
| UPDATE ON THE SUPERA STENT | |
| 8:17 AM - 8:23 AM | Update On The Advantages Of The Supera Vasculomimetic (VMI) Stent For Treating Long Complex Fempop Occlusive Lesions: Is There Value To DCB Vessel Prep First |
|
Presenter(s):Peter C.J. Goverde, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:23 AM - 8:28 AM | Value And Technical Tips To Make The Supera Stent Work In Curved And Angulated Non-SFA Lesion Locations |
|
Presenter(s):Rajiv Parakh, MBBS, MS, FRCS Location: Grand Ballroom East, 3rd Floor |
|
| DRUG ELUTING STENTS FOR BTK LESIONS | |
| 8:29 AM - 8:34 AM | 10-Year Experience With Everolimus DESs To Treat Long Infrapopliteal Lesions Causing CLTI: Indications, Results, Value And Limitations |
|
Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA Location: Grand Ballroom East, 3rd Floor |
|
| 8:35 AM - 8:40 AM | Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5-7 Years: From The DISAPEAR Trial And A Meta-Analysis Of The Absorb Stent From Abbott |
|
Presenter(s):Steven Kum, MD / Ramon L. Varcoe, MBBS, MS, FRACS, PhD Location: Grand Ballroom East, 3rd Floor |
|
| 8:41 AM - 8:46 AM | What Is The Future For Bioresorbable DESs To Treat BTK Lesions: Good Long-Term Results Justify A New Trial: The LIFE-BTK Trial With The Esprit Stent From Abbott |
|
Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD / Sahil A. Parikh, MD / Brian G. DeRubertis, MD Location: Grand Ballroom East, 3rd Floor |
|
| 8:47 AM - 8:52 AM | A 3-French Compatible Microstent (From Micro Medical) For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: The STAND Trial |
|
Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI Location: Grand Ballroom East, 3rd Floor |
|
| 8:53 AM - 9:00 AM | Panel Discussion |
| END OF SESSION 24 | |
| previous | next |